Hopp til innhold
Close

Get alerts of updates about «Perfluoroalkyl substances in maternal plasma during pregnancy and duration of breastfeeding»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Perfluoroalkyl substances in maternal plasma during pregnancy and duration of breastfeeding

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Project

Perfluoroalkyl substances in maternal plasma during pregnancy and duration of breastfeeding - project description

Published Updated

The purpose of this project has been to investigate the association between maternal plasma concentrations of perfluoroalkyl substances (PFAS) and duration of breastfeeding.


Summary

The purpose of this project has been to investigate the association between maternal plasma concentrations of perfluoroalkyl substances (PFAS) and duration of breastfeeding. PFAS are used in industrial and consumer products as surfactants, and are suspected endocrine disruptors. Animal studies show that PFAS can influence mammary gland differentiation and prolactin levels, which suggest that exposure could adversely impact breast milk supply. Two previous studies have tested this hypothesis and examined the association between maternal plasma PFAS concentrations in early pregnancy in relation to duration of breastfeeding, a proxy for breast milk production. We will improve on these analyses by examining the relationship within a large population of primiparas, by utilizing a population that is unlikely to stop breastfeeding prior to 6 months for work-related reasons, and that has measurements on additional PFAS beyond perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA). This analysis will efficiently utilize preexisting measures of PFAS from MoBa participants who were selected as part of a case-control study of preeclampsia, as well as breastfeeding duration data that has been previously characterized within the study population.

 

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Anne Lise Brantsæter, Avdeling for miljøeksponering og -epidemiologi, Norwegian Institute of Public Health

Project participants

Anne Lise Brantsæter, Norwegian Institute of Public Health
Line Småstuen Haug, Avdeling for miljøeksponering og -epidemiologi, Norwegian Institute of Public Health
Matthew P. Longnecker, National Institute of Environmental Health Sciences
Emma Rosen, National Institute of Environmental Health Sciences
Rachel Carroll, National Institute of Environmental Health Sciences

Start

01.04.2017

End

31.03.2021

Status

Active

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health

Project manager

Anne Lise Brantsæter

Participant at FHI

Line Småstuen Haug